European Commission Expands GSK’s RSV Vaccine Use to Adults 18+
London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...
infectious disease
Advertisement
Medincell Secures Gates Grant to Advance Long-Acting Malaria Injection
Montpellier, France, November 24, 2025 — Medincell has announced that it has been awarded up to $3 million in...
Armata Announces Phase 2a Success for S. aureus Phage Therapy
Los Angeles, CA – October 22, 2025 — Armata Pharmaceuticals, Inc., a biotechnology company advancing bacteriophage-based therapeutics, announced positive...
Advertisement
